| Auto Stem Cell Transplant for Lymphoma Patients (NCT03125642) | Masonic Cancer Center, University of Minnesota | 2017-04-20 |
| Relapse Prophylaxis With N-803 for AML and MDS Pts Following Allo HSCT (NCT02989844) | Masonic Cancer Center, University of Minnesota | 2017-04-12 |
| StemRegenin-1 Expanded vs Unexpanded UCB for High Risk Heme Malignancies (NCT02765997) | Masonic Cancer Center, University of Minnesota | 2017-04-01 |
| Study of Brentuximab Vedotin And Bevacizumab In Refractory CD-30 Positive Germ Cell Tumors (NCT02988843) | Masonic Cancer Center, University of Minnesota | 2017-03-29 |
| Allo HSCT Using RIC for Hematological Diseases (NCT02661035) | Masonic Cancer Center, University of Minnesota | 2017-03-09 |
| Adoptive TReg Cell for Suppression of aGVHD After UCB HSCT for Heme Malignancies (NCT02991898) | Masonic Cancer Center, University of Minnesota | 2017-02-16 |
| Reduced Intensity (RIC) Conditioning And Transplantation of HLA-Haplo-HCT (NCT02988466) | Masonic Cancer Center, University of Minnesota | 2017-01-24 |
| Glucobrassicin-Brussel Sprout Effect on D10 Phe Metabolism (NCT02999399) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| Umbilical Cord Blood Transplantation Using a Myeloablative Preparative Regimen for Hematological Diseases (NCT01962636) | Masonic Cancer Center, University of Minnesota | 2016-12-01 |
| Study of Cellutome System for Treatment of Individual Lesions in EB Pts (NCT02670837) | Masonic Cancer Center, University of Minnesota | 2016-08-04 |
| Treg Cells for AGVHD in Non-myeloablative UCB Transplant (NCT02118311) | Masonic Cancer Center, University of Minnesota | 2016-06-01 |
| Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma (NCT02605421) | Masonic Cancer Center, University of Minnesota | 2016-06-01 |
| MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs (NCT02582775) | Masonic Cancer Center, University of Minnesota | 2016-03-01 |
| Study of Pregnyl as Adjunct Therapy for High-Risk or Refractory Acute GVHD (NCT02525029) | Masonic Cancer Center, University of Minnesota | 2016-03-01 |
| Naglazyme After Allo Transplant for Maroteaux-Lamy Syndrome (NCT02156674) | Masonic Cancer Center, University of Minnesota | 2016-01-26 |
| HM2014-26 DT2219 for Relapsed or Refractory B-Lineage Leukemia or Lymphoma (NCT02370160) | Masonic Cancer Center, University of Minnesota | 2015-12-21 |
| Investigation of Kava Effects on NNK Metabolism (NCT02500472) | Masonic Cancer Center, University of Minnesota | 2015-12-03 |
| MT2014-25: Haplo NK With SQ IL-15 in Adult Relapsed or Refractory AML Patients (NCT02395822) | Masonic Cancer Center, University of Minnesota | 2015-10-01 |
| MT2014-14 IT-MSC for Advanced Cerebral Adrenoleukodystrophy (cALD) (NCT02410239) | Masonic Cancer Center, University of Minnesota | 2015-06-01 |
| Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients (NCT02309944) | Masonic Cancer Center, University of Minnesota | 2015-05-01 |
| Safety of Romiplostim (Nplate®) Following UCBT (NCT02046291) | Masonic Cancer Center, University of Minnesota | 2015-04-10 |
| Prevention of Bone Loss After Pediatric Hematopoietic Cell Transplantation (NCT02074631) | Masonic Cancer Center, University of Minnesota | 2015-02-01 |
| MT2013-37R: Voriconazole Monitoring in Pediatric Stem Cell Transplant Patients (NCT02227797) | Masonic Cancer Center, University of Minnesota | 2015-01-19 |
| Hematopoietic Stem Cell Transplant for Dyskeratosis Congenita or Severe Aplastic Anemia (NCT02162420) | Masonic Cancer Center, University of Minnesota | 2015-01-10 |
| Treatment of Graft Failure After Hematopoietic Stem Cell Transplantation (NCT02161783) | Masonic Cancer Center, University of Minnesota | 2014-10-06 |
| Reduced Intensity Conditioning and Haploidentical Related Bone Marrow for Patients With Hematologic Diseases (NCT02145039) | Masonic Cancer Center, University of Minnesota | 2014-10-01 |
| Hematopoietic Stem Cell Transplant for High Risk Hemoglobinopathies (NCT02179359) | Masonic Cancer Center, University of Minnesota | 2014-09-02 |
| Intraperitoneal Natural Killer Cells and INCB024360 for Recurrent Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT02118285) | Masonic Cancer Center, University of Minnesota | 2014-07-28 |
| MT2013-31: Allo HCT for Metabolic Disorders and Severe Osteopetrosis (NCT02171104) | Masonic Cancer Center, University of Minnesota | 2014-07-10 |
| ADAM17 Inhibitor/ Rituximab After Auto HCT for DLBCL (NCT02141451) | Masonic Cancer Center, University of Minnesota | 2014-05-01 |
| T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies (NCT01163201) | Masonic Cancer Center, University of Minnesota | 2014-01-01 |
| Pilot Study of Multi-Modality Imaging in Patients With Hematologic Malignancies (NCT02042924) | Masonic Cancer Center, University of Minnesota | 2014-01-01 |
| DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma (NCT00889408) | Masonic Cancer Center, University of Minnesota | 2013-12-02 |
| Tobacco Constituents and Biomarkers (NCT04090606) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| Clofarabine, Cyclophosphamide and Etoposide for Minimal Residual Disease Positive Acute Leukemia (NCT01677949) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| MIBG for Refractory Neuroblastoma and Pheochromocytoma (NCT01850888) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| AHN-12 Biodistribution in Advanced Leukemia (NCT01207076) | Masonic Cancer Center, University of Minnesota | 2013-12-01 |
| IL-15 Super Agonist ALT-803 to Treat Relapse Of Hematologic Malignancy After Allogeneic SCT (NCT01885897) | Masonic Cancer Center, University of Minnesota | 2013-11-11 |
| Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation (NCT01634217) | Masonic Cancer Center, University of Minnesota | 2013-11-08 |
| CD3/CD19 Depleted or CD3 Depleted/CD56 Selected Haploid Donor Natural Killer Cell Treatment in Older AML in First Complete Remission (NCT01639456) | Masonic Cancer Center, University of Minnesota | 2013-10-01 |
| Vegetable Intake Effect on Heterocyclic Amine Metabolism (NCT04882423) | Masonic Cancer Center, University of Minnesota | 2013-09-19 |
| Decitabine and Vorinostat Conditioning Followed by CD3-/CD19- NK Cells Infusion for High Risk Myelodysplastic Syndromes (NCT01593670) | Masonic Cancer Center, University of Minnesota | 2013-03-01 |
| Implementation of a Rapid Recovery Program in Gynecologic Oncology Surgery: A Pilot Study (NCT01705288) | Masonic Cancer Center, University of Minnesota | 2013-01-01 |
| Busulfan and Cyclophosphamide Followed By ALLO BMT (NCT01685411) | Masonic Cancer Center, University of Minnesota | 2013-01-01 |
| Phase II Study of Sipuleucel-T and Indoximod for Patients With Refractory Metastatic Prostate Cancer (NCT01560923) | Masonic Cancer Center, University of Minnesota | 2012-10-01 |
| Allogeneic Hematopoietic Stem Cell Transplant for Patients With Primary Immune Deficiencies (NCT01652092) | Masonic Cancer Center, University of Minnesota | 2012-09-04 |
| Total Marrow Irradiation for Refractory Acute Leukemia (NCT00686556) | Masonic Cancer Center, University of Minnesota | 2012-08-01 |
| Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC) (NCT01666080) | Masonic Cancer Center, University of Minnesota | 2012-08-01 |
| Imiquimod/Brain Tumor Initiating Cell (BTIC) Vaccine in Brain Stem Glioma (NCT01400672) | Masonic Cancer Center, University of Minnesota | 2012-07-17 |
| Reduced-Intensity Hematopoietic Stem Cell Transplant for High Risk Lysosomal and Peroxisomal Disorders (NCT01626092) | Masonic Cancer Center, University of Minnesota | 2012-07-11 |
| Cancer and Mindfulness-Based Cancer Recovery After Chemotherapy (NCT01601548) | Masonic Cancer Center, University of Minnesota | 2012-07-01 |
| Potentiation of Cetuximab by Tregs Depletion With CSA in Advanced Head & Neck Cancer (NCT01581970) | Masonic Cancer Center, University of Minnesota | 2012-06-01 |
| Administration of IV Laronidase Post Bone Marrow Transplant in Hurler (NCT01173016) | Masonic Cancer Center, University of Minnesota | 2012-05-29 |
| Biomarker Feedback for Smoking Cessation (NCT02206971) | Masonic Cancer Center, University of Minnesota | 2012-05-01 |
| High Dose Chemotherapy and Autologous Transplant for Neuroblastoma (NCT01526603) | Masonic Cancer Center, University of Minnesota | 2012-03-28 |
| Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome (NCT01572636) | Masonic Cancer Center, University of Minnesota | 2012-03-28 |
| Infusion of Cell Populations From Unlicensed Umbilical Cord Blood Units (NCT01451502) | Masonic Cancer Center, University of Minnesota | 2011-10-20 |
| Auto Transplant for High Risk or Relapsed Solid or CNS Tumors (NCT01505569) | Masonic Cancer Center, University of Minnesota | 2011-10-20 |
| T-Cell Depleted Double UCB for Refractory AML (NCT01464359) | Masonic Cancer Center, University of Minnesota | 2011-10-01 |
| NK Cell Based Non-Myeloablative Transplantation in Acute Myeloid Diseases (NCT01370213) | Masonic Cancer Center, University of Minnesota | 2011-09-01 |
| Haploidentical Donor Natural Killer Cell Infusion With IL-15 in Acute Myelogenous Leukemia (AML) (NCT01385423) | Masonic Cancer Center, University of Minnesota | 2011-09-01 |
| Preservation of Ovarian Function After Hematopoietic Cell Transplant (NCT01343368) | Masonic Cancer Center, University of Minnesota | 2011-07-01 |
| Bortezomib, Vorinostat and Dexamethasone for Relapsed/Refractory Acute Lymphoblastic Leukemia (ALL) (NCT01312818) | Masonic Cancer Center, University of Minnesota | 2011-06-01 |
| Selecting a Favorable KIR Donor in Unrelated HCT for AML (NCT01288222) | Masonic Cancer Center, University of Minnesota | 2011-06-01 |
| Metabolism of NNK Among African Americans (NCT01158456) | Masonic Cancer Center, University of Minnesota | 2010-12-01 |
| Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy (NCT01056601) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Vaccination With Dendritic Cells Loaded With Brain Tumor Stem Cells for Progressive Malignant Brain Tumor (NCT01171469) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Influenza Vaccine Post Allogeneic Transplant (NCT01215981) | Masonic Cancer Center, University of Minnesota | 2010-09-01 |
| Penostatin, Rituximab and Ontak and Allogeneic Natural Killer (NK) Cells for Refractory Lymphoid Malignancies (NCT01181258) | Masonic Cancer Center, University of Minnesota | 2010-08-01 |
| WCC# 59 Hyperthermic Intraperitoneal Chemotherapy Utilizing Carboplatin in First Recurrence Ovarian Cancer (NCT01144442) | Masonic Cancer Center, University of Minnesota | 2010-07-27 |
| Haploidentical Natural Killer Cells to Treat Refractory or Relapsed Acute Myelogenous Leukemia (AML) (NCT01106950) | Masonic Cancer Center, University of Minnesota | 2010-07-01 |
| Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast Cancer (NCT01105650) | Masonic Cancer Center, University of Minnesota | 2010-07-01 |
| Ritonavir and Its Effects on Biomarkers in Women Undergoing Surgery for Newly Diagnosed Breast Cancer (NCT01009437) | Masonic Cancer Center, University of Minnesota | 2010-05-26 |
| IL-2 Expressing, Attenuated Salmonella Typhimurium in Unresectable Hepatic Spread (NCT01099631) | Masonic Cancer Center, University of Minnesota | 2010-04-01 |
| Donor Umbilical Cord Blood Transplant After Fludarabine Phosphate, Cyclophosphamide, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Cancer (NCT00963872) | Masonic Cancer Center, University of Minnesota | 2010-03-01 |
| Biochemical Correction of Severe EB by Allo HSCT and "Off-the-shelf" MSCs (NCT01033552) | Masonic Cancer Center, University of Minnesota | 2010-01-01 |
| Allogeneic Bone Marrow Transplant for Inherited Metabolic Disorders (NCT01043640) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Study of Pazopanib and Ixabepilone in Patients With Solid Tumors (NCT01012362) | Masonic Cancer Center, University of Minnesota | 2009-12-01 |
| Lenalidomide and Doxorubicin Hydrochloride Liposome in Recurrent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer (NCT00903630) | Masonic Cancer Center, University of Minnesota | 2009-04-01 |
| Pre-reinductive Decitabine and Vorinostat in Relapsed Lymphoblastic Lymphoma or Acute Lymphoblastic Leukemia (NCT00882206) | Masonic Cancer Center, University of Minnesota | 2009-04-01 |
| Enalapril Maleate and Doxorubicin Hydrochloride in Treating Women With Breast Cancer (NCT00895414) | Masonic Cancer Center, University of Minnesota | 2009-04-01 |
| Bortezomib and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorders (NCT00869323) | Masonic Cancer Center, University of Minnesota | 2009-03-01 |
| Bortezomib and Vorinostat in Treating Patients With High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia (NCT00818649) | Masonic Cancer Center, University of Minnesota | 2009-01-01 |
| Chemotherapy, Total-Body Irradiation, Donor Natural Killer Cell Infusion, Aldesleukin, and UCB Transplant in Treating Patients With Relapsed or Refractory AML (NCT00871689) | Masonic Cancer Center, University of Minnesota | 2009-01-01 |
| Iron Overload in Patients Undergoing Donor Stem Cell Transplant (NCT00888316) | Masonic Cancer Center, University of Minnesota | 2008-12-01 |
| Phase II Study of Allo LMI Vaccine With IL-2 for Stable Metastatic Breast Ca (NCT00784524) | Masonic Cancer Center, University of Minnesota | 2008-09-01 |
| Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases (NCT00769990) | Masonic Cancer Center, University of Minnesota | 2008-09-01 |
| Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Sunitinib as First-Line Therapy in Treating Patients With Stage IV Non-Small Cell Lung Cancer (NCT00748163) | Masonic Cancer Center, University of Minnesota | 2008-08-01 |
| Allogeneic Transplantation For Severe Osteopetrosis (NCT00775931) | Masonic Cancer Center, University of Minnesota | 2008-08-01 |
| Everolimus in Treating Women With Breast Cancer That Can Be Removed by Surgery (NCT00855114) | Masonic Cancer Center, University of Minnesota | 2008-07-01 |
| Donor T Cells in Treating Patients With High-Risk Hematologic Cancer Undergoing Donor Peripheral Blood Stem Cell Transplant (NCT00725062) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Aldesleukin With or Without Vaccine Therapy in Treating Patients With Stage IV Melanoma (NCT00726739) | Masonic Cancer Center, University of Minnesota | 2008-06-01 |
| Sorafenib, Pemetrexed, and Cisplatin in Treating Patients With Advanced Solid Tumors (NCT00703638) | Masonic Cancer Center, University of Minnesota | 2008-05-01 |
| Allogeneic Natural Killer Cells in Patients With Recurrent Ovarian Cancer, Fallopian Tube, and Primary Peritoneal Cancer (NCT00652899) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| Hematopoietic Stem Cell Transplantation (HCT) for Inborn Errors of Metabolism (NCT00668564) | Masonic Cancer Center, University of Minnesota | 2008-03-01 |
| Intrathecal Enzyme Replacement for Hurler Syndrome (NCT00638547) | Masonic Cancer Center, University of Minnesota | 2008-01-02 |
| Yttrium Y 90 Anti-CD19 Antibody BU-12 in Patients With Advanced Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Lymphocytic Leukemia (NCT00643240) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Donor Natural Killer Cell Infusion, Rituximab, Aldesleukin, and Chemotherapy in Treating Patients With Relapsed Non-Hodgkin Lymphoma or Chronic Lymphocytic Leukemia (NCT00625729) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant (NCT00617929) | Masonic Cancer Center, University of Minnesota | 2008-01-01 |
| Hyperthermic Intraperitoneal Oxaliplatin for Peritoneal Malignancies (NCT00625092) | Masonic Cancer Center, University of Minnesota | 2007-10-01 |